Trademarkia Logo

Australia

AU$
EMRUXIV
Registered: Registered/protected

Last updated on 5 Jan 2023

Owner Info

Principia Biopharma Inc.

55 Corporate Drive

Bridgewater, NJ, 08807 UNITED STATES OF AMERICA,

Serial Number

2306249 filed on 10 Oct 2022

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

EMRUXIV

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of multiple sclerosis.

Mark Details


Serial Number

2306249

Registered On

10 Oct 2022

Renewal On

10 Oct 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 May 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
5th Jan 2023IP Right Registered correspondence sent
5th Jan 2023IP Right Registration Published
5th Jan 2023Status change to Registered/Protected
21st Oct 2022Application Accepted correspondence sent
21st Oct 2022IP Right has been Examined
21st Oct 2022IP Right Acceptance Published
19th Oct 2022Status change to Accepted
18th Oct 2022Awaiting examination
18th Oct 2022Examination expedited
10th Oct 2022IP Right Filed correspondence sent